322 related articles for article (PubMed ID: 19095258)
1. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.
Lane BR; Li J; Zhou M; Babineau D; Faber P; Novick AC; Williams BR
J Urol; 2009 Feb; 181(2):849-60. PubMed ID: 19095258
[TBL] [Abstract][Full Text] [Related]
2. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
3. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
5. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
10. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
11. Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers.
Gulati S; Martinez P; Joshi T; Birkbak NJ; Santos CR; Rowan AJ; Pickering L; Gore M; Larkin J; Szallasi Z; Bates PA; Swanton C; Gerlinger M
Eur Urol; 2014 Nov; 66(5):936-48. PubMed ID: 25047176
[TBL] [Abstract][Full Text] [Related]
12. Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
Hakimi AA; Ostrovnaya I; Jacobsen A; Susztak K; Coleman JA; Russo P; Winer AG; Mano R; Sankin AI; Motzer RJ; Voss MH; Offit K; Purdue M; Pomerantz M; Freedman M; Choueiri TK; Hsieh JJ; Klein RJ
Cancer; 2016 Feb; 122(3):402-10. PubMed ID: 26505625
[TBL] [Abstract][Full Text] [Related]
13. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.
Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Sano F; Baba M; Kondo K; Nakaigawa N; Kishida T; Nagashima Y; Yamada-Okabe H; Kubota Y
Int J Cancer; 2008 Sep; 123(5):1126-32. PubMed ID: 18546273
[TBL] [Abstract][Full Text] [Related]
14. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
15. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.
Eisenberg MS; Cheville JC; Thompson RH; Kaushik D; Lohse CM; Boorjian SA; Costello BA; Leibovich BC
J Urol; 2013 Jul; 190(1):37-43. PubMed ID: 23353044
[TBL] [Abstract][Full Text] [Related]
16. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
17. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
Frank I; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Dec; 168(6):2395-400. PubMed ID: 12441925
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract][Full Text] [Related]
19. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]